Editorial: Searching for understanding with the cellular lining of life

Circulation Research

Volumn 106, Issue 10, 2010, Pages 1554-1556

  Penn, Marc S ^a,b   Mayorga, Maritza E ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b Department of Stem Cell Biology and Regenerative Medicine ^*  (United States)

Author keywords

Human amniotic membrane; Mesenchymal stem cells; Multipotent adult progenitor cells; Stem cell therapy

Indexed keywords

HLA G ANTIGEN; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TRANSCRIPTION FACTOR GATA 4; TROPONIN;

ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIGEN EXPRESSION; CELL DIFFERENTIATION; CELL METABOLISM; CELL POPULATION; CELL SURVIVAL; CELL TYPE; CYTOKINE RELEASE; DRUG MECHANISM; EDITORIAL; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CELL; HUMAN; HUMAN AMNIOTIC MEMBRANE DERIVED MESENCHYMAL CELL; MESENCHYMAL STEM CELL; MESENCHYME CELL; NONHUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TREATMENT RESPONSE; ADULT; ALLOTRANSPLANTATION; AMNION; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL TRANSPLANTATION; CYTOLOGY; HEART DISEASE; MESENCHYMAL STEM CELL TRANSPLANTATION; METHODOLOGY; MUSCLE CELL; NOTE; PHYSIOLOGY; STEM CELL;

ADULT; AMNION; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CELL DIFFERENTIATION; HEART DISEASES; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MUSCLE CELLS; STEM CELL TRANSPLANTATION; STEM CELLS; TRANSPLANTATION, HOMOLOGOUS;

EID: 77952978826     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.110.221499     Document Type: Editorial

References (15)

1. Penn MS, Topol E. The challenge for stem cell therapy. In: Penn MS, ed. Stem Cells and Myocardial Regeneration. Totowa: Humana Press; 2007:1-8.
2. Zhang M, Mal N, Kiedrowski M, Chacko M, Askari AT, Popovic ZB, Koc ON, Penn MS. Sdf-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J. 2007;21:3197-3207. (Pubitemid 47565538)
3. Hare J, Traverse J, Henry T, Dib N, Strumpf R, Schulman S, Gerstenblith G, DeMaria A, Denktas A, Gammon R, Hermiller J, Reisman M, Schaer G, Sherman W. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) following acute myocardial infarction. J Am Coll Cardiol. 2009;54:2277-2286.
4. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410: 701-705.
5. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Hol-schermann H, Yu J, Corti R, Mathey DG, Hamm CW, Suselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006;355:1210-1221. (Pubitemid 44427445)
6. Van't HW, Mal N, Huang Y, Zhang M, Popovic Z, Forudi F, Deans R, Penn MS. Direct delivery of syngeneic and allogeneic large-scale expanded multipotent adult progenitor cells improves cardiac function after myocardial infarct. Cytotherapy. 2007;9:477-487.
7. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, Wang J, Homma S, Edwards NM, Itescu S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents car-diomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med. 2001;7:430-436.
8. Tsuji H, Miyoshi S, Ikegami Y, Hida N, Asada H, Togashi I, Suzuki J, Satake M, Nakamizo H, Tanaka M, Mori T, Segawa K, Nishiyama N, Inoue J, Makino H, Miyado K, Ogawa S, Yoshimura Y, Umezawa A. Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyo-cytes. Circ Res. 2010;106:1613-1623.
9. Burchfield JS, Iwasaki M, Koyanagi M, Urbich C, Rosenthal N, Zeiher AM, Dimmeler S. Interleukin-10 from transplanted bone marrow mono-nuclear cells contributes to cardiac protection after myocardial infarction. Circ Res. 2008;103:203-211.
10. Jones RH, Velazquez EJ, Michler RE, Sopko G, Oh JK, O'Connor CM, Hill JA, Menicanti L, Sadowski Z, Desvigne-Nickens P, Rouleau JL, Lee KL. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med. 2009;360:1705-1717.
11. Tang YL, Zhu W, Cheng M, Chen L, Zhang J, Sun T, Kishore R, Phillips MI, Losordo DW, Qin G. Hypoxic preconditioning enhances the benefit of cardiac progenitor-cell therapy for treatment of myocardial infarction by inducing cxcr4 expression. Circ Res. 2009;104:1209-1216.
12. Ziebart T, Yoon CH, Trepels T, Wietelmann A, Braun T, Kiessling F, Stein S, Grez M, Ihling C, Muhly-Reinholz M, Carmona G, Urbich C, Zeiher AM, Dimmeler S. Sustained persistence of transplanted proan-giogenic cells contributes to neovascularization and cardiac function after ischemia. Circ Res. 2008;103:1327-1334.
13. Deglurkar I, Mal N, Mills WR, Popovic ZB, McCarthy P, Blackstone EH, laurita KR, Penn MS. Mechanical and electrical effects of cell-based gene therapy for ischemic cardiomyopathy are independent. Hum Gene Ther. 2006;17:1144-1151.
14. Schenk S, Mal N, Finan A, Zhang M, Kiedrowski M, Popovic Z, McCarthy PM, Penn MS. Monocyte chemotactic protein-3 is a myo-cardial mesenchymal stem cell homing factor. Stem Cells. 2007;25: 245-251.
15. Bian J, Popovic ZB, Benejam C, Kiedrowski M, Rodriguez LL, Penn MS. Effect of cell-based intercellular delivery of transcription factor gata4 on ischemic cardiomyopathy. Circ Res. 2007;100:1626-1633.